Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-008095

President and CEO sold 50,000 shares at an average $41.11 ($2,055,576)

  • President and CEO acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Torley Helen · President and CEO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-10 Exercise or conversion : show line 1 in the form +50,000 $14.66 $733,000 587,160 D
2021-08-10 Sale : show line 2 in the form −25,138 $40.42 $1,016,103 562,022 D
2021-08-10 Sale : show line 3 in the form −21,914 $41.47 $908,752 540,108 D
2021-08-10 Sale : show line 4 in the form −1,000 $42.64 $42,640 539,108 D
2021-08-10 Sale : show line 5 in the form −400 $43.26 $17,304 538,708 D
2021-08-10 Sale : show line 6 in the form −500 $44.91 $22,454 538,208 D
2021-08-10 Sale : show line 7 in the form −1,048 $46.11 $48,323 537,160 D
Open-market sales · 50,000 sh · avg $41.11 · $2,055,576

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2021-08-10 Exercise or conversion : show line 8 in the form Option to Purchase Common Stock −50,000 $14.66 $733,000 $14.66 2024-01-06 50,000 300,000 D
Loading xslF345X03/edgar.xml…